Just like the novel coronavirus itself, the emergence of so-called long COVID has surprised both the patients who couldn’t shake their symptoms and the clinicians who have struggled to provide effective treatments. Now, as the U.S. looks to move past the pandemic, there remain unanswered questions about how this fallout from the virus might hamper some workers and for how long. These uncertainties could have important implications for workers’ compensation. By some measures, one in four patients who get COVID-19—even those with mild or asymptomatic cases—will experience subsequent symptoms that range from muscle and nerve pain to breathing difficulties to anxiety and depression. The scope of the challenge will require providers and employers to better understand the nature of the conditions, their origins, and the best paths for treatment. Watch this on-demand webinar to learn more about long COVID and the implications for workers and employers.
More stories
Workers' Comp
White Paper
From Setback to Comeback: Effective Solutions for Delayed Recovery
Workers' Comp
Podcast
Pulsing Recovery: Bone Growth Stimulation's Impact on Comp
Workers' Comp
Article
Ask The Pharmacist: FDA Approval of Non-Opioid Medication for Acute Pain
Does Journavx offer a safer alternative to opioids for acute pain relief in workers’ compensation? The
Risk & Insurance
In the News
The AI Balancing Act: Navigating Innovation in Workers’ Compensation
Workers' Comp
Article
10 Ways Field Case Management Can Make a Difference
.blockbg:nth-of-type(1n) {background-color: #5A0AA0;} .blockbg:nth-of-type(2n) {background-color: #28005A;} .blockbg { padding: 40px 20px 40p
Workers' Comp
Article
Enlyte’s Medical Price Index – Q1 2025 Report
As reported by the Bureau of Labor and Statistics (BLS) in January 2025 for December 2024, the United States consumer